Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.37

€1.37

-5.520%
-0.08
-5.520%
-

-

 
09:30 / Tradegate WKN: A3H210 / Name: Aap Implantate / Stock / ? /

Aap Implantate AG Stock

Aap Implantate AG took a tumble today and lost -€0.080 (-5.520%).
Our community identified positive and negative aspects for Aap Implantate AG stock for the coming years. 1 users see the criterium "Business model" as a plus for the Aap Implantate AG stock. On the other hand our users think that "Valuation (undervalued/overvalued)" could be a problem in the future.

Pros and Cons of Aap Implantate AG in the next few years

Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-27

At first glance, the financials of Aap Implantate, a company operating within the industry, appears to be a mixed bag. There are certain positive aspects, as well as some areas of concern that potential investors should be aware of. Below is a detailed analysis of the pros and cons associated with the company's financials in order to provide a comprehensive understanding of the business and its potential for growth.

*Pros: *

Revenue and Gross Profit Growth: Aap Implantate has demonstrated consistent growth in its total revenue on a yearly basis from 2020–2022. In addition, the company has been able to maintain a healthy gross profit over these years, with a slight increase between 2020 and 2021.

Comments

The comment is under review

systinvest hat das Wertpapier Aap Implantate AG in seinem Wikifolio Aktienwertselektion mit System gekauft.
Show more

News

EQS-Adhoc: aap Implantate AG: Cash capital increase
EQS-Adhoc: aap Implantate AG: Cash capital increase
EQS-Adhoc: aap Implantate AG: Cash capital increase
EQS-News: aap Implantate AG reports strong growth in Q3/2025: +15%
EQS-News: aap Implantate AG reports strong growth in Q3/2025: +15%
EQS-News: aap Implantate AG reports strong growth in Q3/2025: +15%
EQS-News: aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
EQS-News: aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year
EQS-News: aap confirms Rubino Di Girolamo as CEO through the end of 2028; COO Agnieszka Mierzejewska will leave the company at the end of the year